AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Labcorp Holdings Inc.
Video analysis: LH
All videosNo video analysis for this stock yet. Request one from our team.
News: LH
Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript
Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript
Labcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029
Labcorp Holdings (NYSE:LH) on Thursday presented a comprehensive growth strategy and long-term financial forecast during its 2026 Investor Day.
Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
Reaffirms full-year 2026 guidance Provides long-term outlook through 2029, with compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share (EPS) growth of 8.5% to 11.5% Outlines strategic growth priorities driven by a differentiated platform powered by science, technology and global scale Presents long-term value creation framework driven by sustainable growth, strong cash flow generation and disciplined capital deployment BURLINGTON, N.C., Sept. 10, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today will host its 2026 Investor Day at 9 a.m.
Concurrent Investment Advisors LLC Has $1.50 Million Position in Labcorp Holdings Inc. $LH
Concurrent Investment Advisors LLC grew its holdings in Labcorp Holdings Inc. (NYSE: LH) by 64.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,369 shares of the medical research company's stock after purchasing an additional 2,103 shares during the
Great Point Partners III Sells MLM Medical Labs to Labcorp
GREENWICH, Conn. and MÖNCHENGLADBACH, Germany--(BUSINESS WIRE)--Great Point Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, is pleased to announce that it has sold GPP III portfolio company, MLM Medical Labs (“MLM”), to Labcorp. MLM is a leading provider of global central and specialty lab services supporting clinical trials, biomarker testing, and drug development in the life sciences and biopharma industries.Rohan Saikia, Managing Di.
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept.
Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials
Acquisition establishes Labcorp as the only central laboratory provider with a wholly owned laboratory network across four continents BURLINGTON, N.C., Sept. 8, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa.
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Similar companies
-
Waters Corporation
WAT
·
New York Stock Exchange
Compare
-
Quest Diagnostics Incorporated
DGX
·
New York Stock Exchange
Compare
-
Zimmer Biomet Holdings, Inc.
ZBH
·
New York Stock Exchange
Compare
-
West Pharmaceutical Services, Inc.
WST
·
New York Stock Exchange
Compare
-
Illumina, Inc.
ILMN
·
NASDAQ
Compare
-
DexCom, Inc.
DXCM
·
NASDAQ
Compare